CoChat
Sign Up
Cited by 172

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Peptide ligand-mediated targeted drug delivery of nanomedicines

Jiang, Zhuxuan, Guan, Juan, Qian, Jun, Zhan, Changyou·2019·Biomaterials Science
DOI 10.1039/c8bm01340c
Open this paper in CoChat — free account

Abstract

Targeted drug delivery is emerging as a promising strategy to achieve better clinical outcomes.

Overview

Integrity signals

Registry

Crossref · 10.1039/c8bm01340c

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 4 references

Research works printed but not linked: 130

  1. Matsumura, 1986, Cancer Res., 46, 6387
  2. Sakurai, 2014, Expert Opin. Drug Delivery, 12, 41, 10.1517/17425247.2015.955847 · DOI
  3. Antignani, 2013, Toxins, 5, 1486, 10.3390/toxins5081486 · DOI
  4. Hasan, 2018, Curr. Clin. Pharmacol., 13, 236, 10.2174/1574884712666180802095521 · DOI
  5. Sapra, 2013, Pharmacol. Ther., 138, 452, 10.1016/j.pharmthera.2013.03.004 · DOI
  6. Maruyama, 1995, Biochim. Biophys. Acta, 1234, 74, 10.1016/0005-2736(94)00263-O · DOI
  7. Paszko, 2012, Curr. Med. Chem., 19, 5239, 10.2174/092986712803833362 · DOI
  8. Drummond, 2008, J. Pharm. Sci., 97, 4696, 10.1002/jps.21358 · DOI
  9. Xiao, 2012, ACS Nano, 6, 3670, 10.1021/nn301869z · DOI
  10. Li, 2013, J. Controlled Release, 171, 152, 10.1016/j.jconrel.2013.06.006 · DOI
  11. Mongelard, 2010, Curr. Opin. Mol. Ther., 12, 107
  12. Bailey, 1999, J. Nutr., 129, 779, 10.1093/jn/129.4.779 · DOI
  13. Low, 2008, Acc. Chem. Res., 41, 120, 10.1021/ar7000815 · DOI
  14. Gabizon, 2003, Clin. Cancer Res., 9, 6551
  15. Kue, 2016, Med. Res. Rev., 36, 494, 10.1002/med.21387 · DOI
  16. Leamon, 2003, Bioconjugate Chem., 14, 738, 10.1021/bc020089t · DOI
  17. Liu, 2010, Biomaterials, 31, 330, 10.1016/j.biomaterials.2009.09.036 · DOI
  18. Bae, 2007, Biomacromolecules, 8, 650, 10.1021/bm0608939 · DOI
  19. Sapra, 2003, Prog. Lipid Res., 42, 439, 10.1016/S0163-7827(03)00032-8 · DOI
  20. Sikorski, 2014, Int. J. Nanomed., 1399
  21. Oršolić, 2012, Cancer Metastasis Rev., 31, 173, 10.1007/s10555-011-9339-3 · DOI
  22. Arruda, 2015, Curr. Protein Pept. Sci., 16, 532, 10.2174/1389203716666150515125002 · DOI
  23. Bachran, 2016, Toxins, 8, 197, 10.3390/toxins8070197 · DOI
  24. Burgus, 1973, Proc. Natl. Acad. Sci. U. S. A., 70, 684, 10.1073/pnas.70.3.684 · DOI
  25. Pless, 1986, Scand. J. Gastroenterol., Suppl., 119, 54, 10.3109/00365528609087432 · DOI
  26. Patel, 1995, Life Sci., 57, 1249, 10.1016/0024-3205(95)02082-T · DOI
  27. Hofsli, 2002, Tidsskr. Nor. Laegeforen., 122, 487
  28. Vaidyanathan, 2007, Bioconjugate Chem., 18, 2122, 10.1021/bc700240r · DOI
  29. Shen, 2008, Eur. J. Pharmacol., 601, 23, 10.1016/j.ejphar.2008.10.035 · DOI
  30. Sun, 2010, Nanotechnology, 21, 475101, 10.1088/0957-4484/21/47/475101 · DOI
  31. Li, 2016, Drug Delivery, 23, 3562, 10.1080/10717544.2016.1209797 · DOI
  32. Zhang, 2012, Biomaterials, 33, 679, 10.1016/j.biomaterials.2011.09.072 · DOI
  33. Erspamer, 1970, J. Pharm. Pharmacol., 22, 875, 10.1111/j.2042-7158.1970.tb08465.x · DOI
  34. Märki, 1981, Peptides, 2, 169, 10.1016/0196-9781(81)90027-9 · DOI
  35. Accardo, 2012, J. Drug Targeting, 21, 240, 10.3109/1061186X.2012.741138 · DOI
  36. Conceição, 2016, Data Brief, 6, 700, 10.1016/j.dib.2016.01.017 · DOI
  37. Cook, 2015, J. Controlled Release, 220, 89, 10.1016/j.jconrel.2015.10.013 · DOI
  38. Kim, 2013, Biomaterials, 34, 1170, 10.1016/j.biomaterials.2012.09.047 · DOI
  39. Oswald, 2017, Mol. Pharmaceutics, 14, 2177, 10.1021/acs.molpharmaceut.7b00158 · DOI
  40. Lee, 2017, Adv. Mater., 29, 1605563, 10.1002/adma.201605563 · DOI
  41. Zhan, 2015, Adv. Drug Delivery Rev., 90, 101, 10.1016/j.addr.2015.04.025 · DOI
  42. Zhan, 2010, Mol. Pharmaceutics, 7, 1940, 10.1021/mp100238j · DOI
  43. Nirthanan, 2002, J. Biol. Chem., 277, 17811, 10.1074/jbc.M111152200 · DOI
  44. Zhan, 2011, Angew. Chem., Int. Ed., 50, 5482, 10.1002/anie.201100875 · DOI
  45. Oller-Salvia, 2016, Angew. Chem., 128, 582, 10.1002/ange.201508445 · DOI
  46. Smith, 1985, Science, 228, 1315, 10.1126/science.4001944 · DOI · Paper page
  47. Laakkonen, 2002, Nat. Med., 8, 751, 10.1038/nm720 · DOI
  48. Luo, 2010, Int. J. Pharm., 385, 150, 10.1016/j.ijpharm.2009.10.014 · DOI
  49. Uchida, 2011, ACS Nano, 5, 2493, 10.1021/nn102863y · DOI
  50. Lo, 2008, Mol. Cancer Ther., 7, 579, 10.1158/1535-7163.MCT-07-2359 · DOI
  51. Ashley, 2011, Nat. Mater., 10, 389, 10.1038/nmat2992 · DOI
  52. Ashley, 2011, ACS Nano, 5, 5729, 10.1021/nn201397z · DOI · Paper page
  53. Medina, 2013, Adv. Healthcare Mater., 2, 1337, 10.1002/adhm.201200406 · DOI
  54. Binetruy-Tournaire, 2000, EMBO J., 19, 1525, 10.1093/emboj/19.7.1525 · DOI
  55. Niescioruk, 2017, J. Nanopart. Res., 19, 160, 10.1007/s11051-017-3859-x · DOI
  56. Wang, 2018, J. Controlled Release, 284, 26, 10.1016/j.jconrel.2018.06.006 · DOI
  57. Ying, 2016, J. Controlled Release, 243, 86, 10.1016/j.jconrel.2016.09.035 · DOI
  58. Arap, 1998, Science, 279, 377, 10.1126/science.279.5349.377 · DOI
  59. Pasqualini, 2000, Cancer Res., 60, 722
  60. Pastorino, 2006, Cancer Res., 66, 10073, 10.1158/0008-5472.CAN-06-2117 · DOI
  61. Garde, 2007, Anti-Cancer Drugs, 18, 1189, 10.1097/CAD.0b013e3282a213ce · DOI
  62. Yang, 2014, Biomaterials, 35, 4368, 10.1016/j.biomaterials.2014.01.076 · DOI
  63. Lin, 2015, J. Drug Targeting, 24, 134, 10.3109/1061186X.2015.1058802 · DOI
  64. Yang, 2015, J. Pharm. Sci., 104, 1328, 10.1002/jps.24333 · DOI
  65. Pierschbacher, 1984, Nature, 309, 30, 10.1038/309030a0 · DOI
  66. Urtreger, 1997, Int. J. Oncol., 11, 489
  67. Urtreger, 1999, Int. J. Cancer, 82, 748, 10.1002/(SICI)1097-0215(19990827)82:5<748::AID-IJC20>3.0.CO;2-R · DOI
  68. Haubner, 1996, J. Am. Chem. Soc., 118, 7461, 10.1021/ja9603721 · DOI
  69. Nasongkla, 2004, Angew. Chem., Int. Ed., 43, 6323, 10.1002/anie.200460800 · DOI
  70. Zhan, 2010, J. Controlled Release, 143, 136, 10.1016/j.jconrel.2009.12.020 · DOI
  71. Graf, 2012, ACS Nano, 6, 4530, 10.1021/nn301148e · DOI
  72. Sun, 2015, J. Biomed. Nanotechnol., 11, 1339, 10.1166/jbn.2015.2079 · DOI
  73. Shi, 2015, J. Controlled Release, 217, 138, 10.1016/j.jconrel.2015.09.009 · DOI
  74. Teesalu, 2009, Proc. Natl. Acad. Sci. U. S. A., 106, 16157, 10.1073/pnas.0908201106 · DOI · Paper page
  75. Sugahara, 2009, Cancer Cell, 16, 510, 10.1016/j.ccr.2009.10.013 · DOI
  76. Marelli, 2013, Front. Oncol., 3, 222, 10.3389/fonc.2013.00222 · DOI
  77. Rejeeth, 2016, Artif. Cells, Nanomed., Biotechnol., 45, 489, 10.1080/21691401.2016.1175443 · DOI
  78. Ruoslahti, 2012, Adv. Mater., 24, 3747, 10.1002/adma.201200454 · DOI
  79. Lam, 1991, Nature, 354, 82, 10.1038/354082a0 · DOI
  80. Jia, 2017, Biomater. Sci., 5, 417, 10.1039/C6BM00898D · DOI
  81. Qian, 2015, Methods Mol. Biol., 1248, 39, 10.1007/978-1-4939-2020-4_3 · DOI
  82. Liu, 2017, Adv. Drug Delivery Rev., 110–111, 13, 10.1016/j.addr.2016.05.009 · DOI
  83. Martinez-Ceron, 2016, Curr. Pharm. Biotechnol., 17, 449, 10.2174/1389201017666160114095553 · DOI
  84. Xiao, 2010, Mol. Cancer Ther., 9, 2714, 10.1158/1535-7163.MCT-10-0308 · DOI
  85. Wang, 2016, Mol. Cancer Ther., 15, 232, 10.1158/1535-7163.MCT-15-0544 · DOI
  86. Aina, 2005, Mol. Imaging, 4, 439, 10.2310/7290.2005.05169 · DOI
  87. Xiao, 2012, Cancer Res., 72, 2100, 10.1158/0008-5472.CAN-11-3883 · DOI
  88. Zhang, 2012, Urol. Oncol.: Semin. Orig. Invest., 30, 635, 10.1016/j.urolonc.2010.06.011 · DOI
  89. Pan, 2012, Int. J. Nanomed., 7, 2793, 10.2147/IJN.S27734 · DOI
  90. Pan, 2016, Nanotechnology, 27, 425103, 10.1088/0957-4484/27/42/425103 · DOI
  91. Geng, 2016, Theranostics, 6, 1261, 10.7150/thno.14302 · DOI
  92. Xu, 2003, J. Biomed. Biotechnol., 2003, 257, 10.1155/S1110724303209220 · DOI
  93. Zambaldo, 2015, Curr. Opin. Chem. Biol., 26, 8, 10.1016/j.cbpa.2015.01.005 · DOI
  94. Uttamchandani, 2006, Mol. BioSyst., 2, 58, 10.1039/B513935J · DOI
  95. Ruan, 2017, ACS Appl. Mater. Interfaces, 9, 17745, 10.1021/acsami.7b03682 · DOI
  96. Zhang, 2018, Mol. Pharmaceutics, 15, 430, 10.1021/acs.molpharmaceut.7b00801 · DOI
  97. Liu, 2016, Chem. Rec., 16, 1772, 10.1002/tcr.201600005 · DOI
  98. Goodman, 2002, Acc. Chem. Res., 12, 1, 10.1021/ar50133a001 · DOI
  99. Shao, 2010, J. Controlled Release, 147, 118, 10.1016/j.jconrel.2010.06.018 · DOI
  100. Xin, 2012, Biomaterials, 33, 1673, 10.1016/j.biomaterials.2011.11.018 · DOI
  101. Wei, 2014, Mol. Pharmaceutics, 11, 3261, 10.1021/mp500086e · DOI
  102. Wei, 2015, Angew. Chem., Int. Ed., 54, 3023, 10.1002/anie.201411226 · DOI
  103. Prades, 2015, Angew. Chem., Int. Ed., 54, 3967, 10.1002/anie.201411408 · DOI
  104. Li, 2010, J. Biol. Chem., 285, 19572, 10.1074/jbc.M110.116814 · DOI
  105. Schumacher, 1996, Science, 271, 1854, 10.1126/science.271.5257.1854 · DOI
  106. Sun, 2012, J. Biotechnol., 161, 121, 10.1016/j.jbiotec.2012.05.019 · DOI
  107. Li, 2017, Bioconjugate Chem., 28, 2167, 10.1021/acs.bioconjchem.7b00326 · DOI
  108. Shannahan, 2015, Toxicol. Sci., 143, 136, 10.1093/toxsci/kfu217 · DOI
  109. Hulander, 2011, Int. J. Nanomed., 6, 2653, 10.2147/IJN.S24578 · DOI
  110. Gheshlaghi, 2008, Acta Biochim. Biophys. Sin., 40, 777, 10.1093/abbs/40.9.777 · DOI
  111. Guan, 2018, Nat. Commun., 9, 2982, 10.1038/s41467-018-05384-1 · DOI · Paper page
  112. Caracciolo, 2015, Nanomedicine, 11, 543, 10.1016/j.nano.2014.11.003 · DOI
  113. Karmali, 2011, Expert Opin. Drug Delivery, 8, 343, 10.1517/17425247.2011.554818 · DOI
  114. Hadjidemetriou, 2017, Nat. Nanotechnol., 12, 288, 10.1038/nnano.2017.61 · DOI
  115. Skubitz, 2017, Cancer Chemother. Pharmacol., 80, 787, 10.1007/s00280-017-3420-8 · DOI
  116. Tran, 2017, Clin. Transl. Med., 6, 44, 10.1186/s40169-017-0175-0 · DOI · Paper page
  117. Y. Franco , T.Vaidya and S.Ait-Oudhia , Breast Cancer , Dove Med Press , 2018 , vol. 10 , pp. 131–141
  118. Iwamoto, 2013, Biol. Pharm. Bull., 36, 715, 10.1248/bpb.b12-01102 · DOI
  119. Lotem, 2000, Arch. Dermatol., 136, 1475, 10.1001/archderm.136.12.1475 · DOI
  120. Lorusso, 2007, Ann. Oncol., 18, 1159, 10.1093/annonc/mdl477 · DOI
  121. Nakahara, 1996, J. Biol. Chem., 271, 27221, 10.1074/jbc.271.44.27221 · DOI
  122. Ren, 2014, Drug Delivery, 23, 1763, 10.3109/10717544.2015.1077293 · DOI · Paper page
  123. Jin, 2016, Int. J. Pharm., 513, 138, 10.1016/j.ijpharm.2016.08.048 · DOI
  124. Bashari, 2017, Cancer Lett., 408, 164, 10.1016/j.canlet.2017.08.040 · DOI
  125. Eyvazi, 2017, Immunol. Lett., 190, 240, 10.1016/j.imlet.2017.08.028 · DOI
  126. Zhou, 2017, Eur. J. Pharm. Biopharm., 120, 80, 10.1016/j.ejpb.2017.08.011 · DOI
  127. Fukuta, 2017, Int. J. Pharm., 524, 364, 10.1016/j.ijpharm.2017.03.059 · DOI
  128. Tan, 2018, Anal. Bioanal. Chem., 410, 1071, 10.1007/s00216-017-0664-4 · DOI
  129. Bakhshinejad, 2018, Iran. J. Pharm. Res., 17, 396
  130. Fogal, 2008, Cancer Res., 68, 7210, 10.1158/0008-5472.CAN-07-6752 · DOI

Cited by

Sorted by citations

Metadata

Authors
Jiang, Z., Guan, J., Qian, J., & Zhan, C.
Venue
Biomaterials Science
Publisher
Royal Society of Chemistry (RSC)
Published
2019
Volume
7
Issue
2
Pages
461-471
ISSN
  • 2047-4830
  • 2047-4849
DOI
10.1039/c8bm01340c
Cited by
172
References
4
Language
en
Licence
rsc.li/journals-terms-of-use (am, 382 d)
Funders
  • Natural Science Foundation of Shanghai (18ZR1404800)
  • National Natural Science Foundation of China (81673361, 81673370, 81690263, 81803455)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review